组织衍生性 ангиотензиноген对损伤和阻塞性病中的纤维化的影响
Hee-Seong Jang1,2,3, Mi Ra Noh4,3, Ligyeom Ha3
1Milton and Carroll Petrie Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, U.S.A.; hjang17@jhmi.edu.
In vivo (Athens, Greece)
|August 26, 2024
概括
调查纤维化,这项研究发现,虽然肝脏和靠近管管血管增生素 (AGT) 具有不同的作用,但抑制它们并不能防止损伤. 这突出了阻塞性病中复杂的氨酸-血管酶系统.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 分子生物学分子生物学
- 身体生理学 身体生理学
背景情况:
- ангиотензиноген (AGT) 对于调节血压,炎症和纤维化至关重要.
- 组织衍生的AGT在纤维化中的特定作用,独立于血压,需要进一步阐明.
- 阻塞性病是一种独立于系统血压变化的损伤和纤维化研究模型.
研究的目的:
- 在阻塞性病期间确定内AGT的主要来源.
- 研究组织特异性AGT在损伤和纤维化中的作用.
- 在损伤的背景下,了解肝脏和近道管AGT之间的相互作用.
主要方法:
- 使用近接管体特异性AGT淘汰 (PKO) 和肝脏特异性AGT淘汰 (LKO) 的小鼠.
- 诱导单边尿路阻塞 (UUO) 来建模血压独立的纤维化.
- 分析了AGT mRNA和蛋白质水平,以及脏组织中的巨氨酸表达.
主要成果:
- 单边尿路阻塞 (UUO) 增加了脏的AGT mRNA和蛋白质.
- 在UUO期间,来自肝脏的AGT有助于内AGT蛋白水平.
- 靠近管道和肝脏AGT淘汰都没有防止UUO诱导的管道损伤和纤维化.
结论:
- 肝脏和靠近管管的AGT在UUO期间在调节内AGT水平方面表现出不同的作用.
- 这些AGT来源的遗传抑制并没有改善损伤或纤维化.
- 阻塞性病中的氨酸-血管素系统涉及复杂的信号和补偿机制.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
405
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
405
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
522
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
522
01:25Antihypertensive Drugs: Direct Renin Inhibitors
512
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
512